The evidence field · updated daily
8,080
peptide studies,
read so you don't have to.
Every randomized trial, cohort, review and preclinical paper on the peptides people actually use — pulled from PubMed, ClinicalTrials.gov, EuropePMC and PubChem, distilled into a plain-English digest, tagged by evidence strength, and laid out below as a living map of the field.
-
OVASIS (GnRHa) at 1.0 mL/kg BW optimizes captive breeding in ornamental snakehead Channa andrao.
OVASIS (GnRHa) at **1.0 mL/kg BW** achieved **83.3%** spawning success in *Channa andrao*, reducing latency and boosting fecundity, establishing a key breeding protocol.
-
Water-soluble β-strand peptidomimetics designed for diverse sequences and aqueous target binding
This advance provides a robust platform for designing novel therapeutics that can effectively modulate **protein-protein interactions**, a notoriously difficult class of targets. For peptide users and biohackers, this research highlights…
-
Setmelanotide emerges as key pharmacologic intervention for hypothalamic obesity, targeting `MC4R` pathway amidst complex management challenges.
Setmelanotide, an `MC4R` agonist, is a newly FDA-approved pharmacologic intervention for **hypothalamic obesity** management.
-
Aquatic Exercise Program to Assess Cognition and Mobility in Older Adults with Cognitive Decline
If successful, this research could establish **aquatic exercise as a viable, accessible, and low-impact intervention** for improving cognitive and physical health in older adults, particularly those with **Type 2 Diabetes** and existing …
-
Longitudinal study protocol to investigate HIIT-induced neurophysiological and psychomotor plasticity in Parkinson's disease
This study, once completed, could provide crucial insights into the neurobiological mechanisms underlying the benefits of exercise in **Parkinson's Disease**. **Understanding how HIIT impacts cortical motor structures, psychomotor behavi…
-
Prospective Cohort to Investigate Protein Intake, Nutritional Status, and Recovery After Hip Fracture
If the proposed research identifies strong associations between **protein intake**, **nutritional status**, and improved recovery after **hip fracture**, it could significantly impact post-surgical care. **Optimizing nutritional support*…
-
Long-term Somatropin (Norditropin®) treatment in adults evaluated for safety and efficacy
**Long-term safety and efficacy data for somatropin are crucial for optimizing adult growth hormone deficiency (AGHD) management.** If positive, this study could reinforce current clinical guidelines for Norditropin® use, potentially inf…
-
TTA-121 Trial Commences to Address Autism Spectrum Disorder
A new clinical trial has been initiated to evaluate the efficacy and safety of **TTA-121** for individuals with autism spectrum disorder.
-
Tranexamic Acid Efficacy in Preventing Postpartum Hemorrhage After Elective C-Section to be Assessed in Large RCT
If this large, adequately powered randomized controlled trial validates the efficacy of **Tranexamic Acid** in preventing **Postpartum Haemorrhage** after elective caesarean section, it could significantly impact global maternal health. …
-
High vs. Low Dose Oxytocin RCT Compares Caesarean Rates in Delayed Labor Augmentation
Establishing clear, evidence-based routines for **oxytocin** treatment in **delayed labor** is paramount, given its widespread use and the significant implications for maternal and neonatal health. The findings from this study, once publ…
-
Oral Oxytocin (24IU) to be investigated for modulating attention control in social-emotional eye-tracking tasks
Oral oxytocin (24IU) will be investigated for its ability to modulate attention control using a social-emotional saccade/antisaccade eye-tracking paradigm.
-
Liraglutide efficacy in insulin-resistant Type 2 diabetes patients on high insulin doses investigated
A study aims to assess if adding liraglutide improves blood glucose in Type 2 diabetes patients on >50 U/day insulin, who often fail to meet HbA1C targets.
-
Semaglutide microdosing trial aims to prevent weight regain and improve cardiometabolic health in PWH
If successful, this trial could establish a **semaglutide microdosing protocol** as a viable and potentially more tolerable strategy for long-term weight management and cardiometabolic health in **PWH**. For peptide users and clinicians,…
-
Oral Semaglutide Dose-Ranging Trial Completed for Type 2 Diabetes Efficacy and Safety
Oral semaglutide's dose range, escalation, and efficacy were examined in a global Phase 3 trial for Type 2 Diabetes, now completed.
-
Semaglutide and Tirzepatide Therapy Evaluated for Early Hepatic and Metabolic Index Changes in Overweight/Obese MASLD Patients
This study highlights the ongoing interest in incretin therapies like semaglutide and tirzepatide for managing **MASLD**, beyond their established roles in obesity and diabetes. While specific numerical outcomes are not detailed in the a…
-
Primary Care Physicians Unprepared to Manage Weight Loss After GLP-1 Drug Coverage Loss
Half of surveyed PCPs felt uncomfortable managing patient weight after GLP-1 drug coverage loss, highlighting a need for more resources.
-
Atogepant versus topiramate trial (TEMPLE) evaluated tolerability, safety, and efficacy in migraine prevention.
The TEMPLE trial, a phase 3b study, aimed to compare atogepant 60 mg daily against topiramate for tolerability, safety, and efficacy in adults with migraine.
-
Pectin **147-02-S2** from *Sanguisorba officinalis* roots alleviates colitis via `TLR4/MyD88` and `NF-κB` inhibition.
Pectin **147-02-S2**, isolated from *Sanguisorba officinalis*, suppressed `TNF-α` and `IL-1β` in LPS-stimulated cells and alleviated DSS-induced colitis in mice via `TLR4/MyD88` and `NF-κB` inhibition.
-
Retatrutide's UTI signal: Investigating the role of administration timing
Understanding the relationship between **Retatrutide** and **urinary tract infection** signals, especially concerning administration timing, is critical for patient safety and optimizing therapeutic protocols. If Retatrutide influences U…
-
Protocol details Chemerin 15's microglial phagocytosis enhancement in cerebral ischemia-reperfusion injury via ChemR23/p38 MAPK.
**This standardized protocol offers a robust toolkit for researchers investigating novel neuroprotective strategies in cerebral ischemia-reperfusion injury.** For peptide users and biohackers, understanding the precise mechanisms of **Ch…
-
Engineered Bifidobacterium secreting Super-mutant IL-2 significantly suppressed pancreatic cancer growth in mice
This research introduces a **novel, tumor-targeted immunotherapy strategy for PDAC** that could significantly enhance treatment efficacy. By leveraging engineered probiotics to deliver a Teff-selective IL-2 variant directly to the **TME*…
-
Plasminogen System: A Versatile Regulator of Fibrinolysis, Inflammation, and Tissue Remodeling in Health and Disease
**Understanding the plasminogen system's dual role as a guardian and disease driver is crucial for developing novel therapeutic strategies.** This review consolidates decades of knowledge, offering a roadmap for targeting its components …
-
Exercise and Protein Supplementation Project to Investigate Synergistic Effects on Age-Related Sarcopenia
A recruiting clinical trial will investigate combined aerobic and resistance exercise with protein supplementation for age-related sarcopenia outcomes.
-
rhIGF-1 Hypothesized to Improve Bone Density and Microarchitecture in Adolescent Girls with Anorexia Nervosa
rhIGF-1 is hypothesized to improve bone density and microarchitecture in adolescent girls with **anorexia nervosa** over a 6-month period, addressing **IGF-1** deficiency.
-
SPARK Digital Platform Aims to Improve Gestational Diabetes Self-Management and Prevent Adverse Outcomes
If successful, the **SPARK** digital platform could revolutionize **Gestational Diabetes Mellitus (GDM)** management by offering a scalable, accessible, and less burdensome alternative to traditional care. **This could empower women with…
-
Norditropin® treatment efficacy score (GET-score) validated in European adult growth hormone deficiency patients
Developing a validated, comprehensive score like the GET-score for **growth hormone deficiency (GHD)** treatment could significantly improve patient care and research. **Clinicians could gain a more objective and holistic tool to monitor…
-
Paint-by-Numbers activity explored for reducing stress and enhancing prenatal attachment in high-risk pregnancies
If effective, **Paint-by-Numbers activity could offer a simple, accessible, and low-cost non-pharmacological intervention** for managing stress and promoting maternal-fetal bonding in high-risk pregnancies. This could empower pregnant wo…
-
Misoprostol vs. Foley's Catheter/Oxytocin Compared for Second Trimester Pregnancy Termination in Previous C-Section Patients
While this abstract does not provide specific findings, the study design addresses a crucial clinical question for **women with previous Caesarean sections** undergoing second trimester pregnancy termination. Identifying a superior metho…
-
Intranasal Oxytocin Hypothesized to Improve Social Function in Adults with Autism Spectrum Disorders
Rigorous evaluation of **intranasal oxytocin (IN-OXT)** as a potential treatment for social dysfunction in adults with **Autism Spectrum Disorders (ASD)** is a crucial step. Given the significant unmet need for effective therapies as ind…
-
Prophylactic Amnioinfusion Study Aims to Decrease Composite Postpartum Hemorrhage Morbidity
If successful, **prophylactic amnioinfusion could offer a novel, non-pharmacological strategy to significantly reduce the incidence and severity of postpartum hemorrhage**, potentially saving lives and preventing severe maternal complica…
-
Water Birth and Epidural Analgesia Compared for Maternal and Neonatal Safety Outcomes
Understanding the comparative safety and effectiveness of **water birth** versus **epidural analgesia** is vital for empowering women to make informed choices about their labor and delivery. If future findings provide clear evidence on s…
-
Misoprostol vs. Oxytocin Compared for Preinduction Cervical Ripening Efficacy
**Identifying an optimal strategy for cervical ripening** could significantly impact obstetric practice, potentially reducing **cesarean section** rates and improving maternal satisfaction. If **misoprostol** preinduction proves superior…
-
NNC9204-0530 and Liraglutide Combination Safety, PK Explored in Overweight Males
Safety, tolerability, and pharmacokinetics of single doses of **NNC9204-0530** alone and with **liraglutide** are being investigated in overweight/obese males.
-
Liraglutide in Type 1 Diabetes Hypothesized to Improve Glucose Control, Insulin Sensitivity, and Body Composition
A 52-week trial hypothesized **Liraglutide** with insulin would improve glucose control, insulin sensitivity, and reduce abdominal fat in overweight **Type 1 diabetes** patients.
-
Real-World Study to Evaluate GLP-1 Receptor Agonist Effectiveness and Persistence in Type 2 Diabetes
A real-world retrospective study aims to assess the long-term effectiveness and treatment persistence of GLP-1RAs in type 2 diabetes patients from 2010-2018.
-
Humedica EHR Data Estimates Malignancy and Pancreatitis Rates in Liraglutide Initiator and LEADER Trial-Representative Cohorts
Once published, the estimated real-world incidence rates for **malignant neoplasms** and **acute pancreatitis** in **Liraglutide** users will provide crucial data for clinicians and patients. This information can help contextualize the s…
-
Semaglutide-Based Triple Therapy Protocol Proposed for Newly Diagnosed Type 2 Diabetes Remission
A multicenter RCT will compare a **semaglutide**-based triple regimen (with metformin + empagliflozin) against sitagliptin-based triple therapy in 240 newly diagnosed T2DM patients.
-
Semaglutide slows epigenetic aging in HIV-associated lipohypertrophy patients over 32 weeks
This finding suggests a novel, broader benefit of **semaglutide** beyond its established metabolic effects, potentially impacting biological aging in a population often facing accelerated aging due to chronic HIV infection and associated…
-
Digital Lifestyle Program to Assess Weight Maintenance After Stopping GLP-1 Medications
This study addresses a crucial, unmet need for individuals transitioning off GLP-1 medications, offering a potential strategy to **sustain weight loss long-term**. If the digital lifestyle program proves effective, it could provide an af…
-
NNC0519-0130 dose-finding trial initiated for weekly subcutaneous injection in individuals with excess body weight
The initiation of this dose-finding study for NNC0519-0130 is a significant step towards potentially expanding the therapeutic arsenal for **obesity treatment**. If successful, a once-weekly subcutaneous injection could offer a highly co…
-
Tirzepatide to be evaluated for epigenetic aging and metabolic restoration in HIV-positive individuals with obesity
A pilot study will evaluate **tirzepatide**'s impact on epigenetic aging and metabolic health in virally suppressed people with **HIV** and obesity.
-
Prospective Study to Evaluate Early Proctologic Effects of GLP-1 Receptor Agonists in Morbid Obesity
**Understanding the full safety and side-effect profile of GLP-1 receptor agonists is crucial for informed clinical practice and patient counseling.** If this study reveals a significant association between GLP-1 RA therapy and the devel…
-
Engineered Switch-IL-12 antibody conditionally activates IL-12 only in presence of tumor antigen Fibronectin-EDB
This engineered **Switch-IL-12** antibody represents a significant step towards overcoming the systemic toxicity limitations of **IL-12** immunotherapy, potentially unlocking its full therapeutic potential for solid tumors. **Conditional…
-
Orforglipron (OFG) 45 mg achieved **12.13 kg** weight loss and **-1.65%** HbA1c reduction
Orforglipron (OFG) 45 mg reduced body weight by **12.13 kg** and HbA1c by **1.65%** in adults with or without diabetes.
-
Sequential Complement and BAFF/APRIL Blockade Reduces Proteinuria, Stabilizes Kidney Function in Aggressive IgAN/IgAVN
This case report suggests a promising new therapeutic avenue for individuals with aggressive **IgA nephropathy (IgAN)** or **IgA vasculitis nephritis (IgAVN)**, where current treatments are often inadequate. **Combining complement inhibi…
-
Strategies to enhance CAR-NK cell persistence for improved cancer immunotherapy efficacy
Understanding and implementing these diverse strategies is crucial for unlocking the full therapeutic potential of **CAR-NK cell therapy**, particularly in challenging contexts like solid tumors where current efficacy is often limited. T…
-
Vitamin C Enhances Human Allospecific Induced Treg Stability and Function via FOXP3 Demethylation
Vitamin C supplementation during expansion significantly improved human induced Treg (iTreg) phenotypic and functional stability, reducing `FOXP3` TSDR methylation from **85.9%** to **43.5%**.
-
Electroacupuncture targets `β2-adrenergic receptor`, reversing eosinophil infiltration and inflammation in mouse allergic rhinitis.
Electroacupuncture (EA) significantly reduced nasal eosinophil infiltration and inflammatory markers in a mouse model of allergic rhinitis by modulating the `β2-adrenergic receptor`.
-
Yangxin Tongluo Decoction protects against sepsis-associated cardiac dysfunction by activating Nrf2 pathway
Yangxin Tongluo Decoction (YXTLD) significantly improved cardiac function and reduced myocardial injury in septic mice by regulating the `Nrf2` pathway.
-
Liraglutide therapy induces 22.2 kg weight loss in young man with Smith-Magenis syndrome and severe obesity.
This case report provides crucial insights into the potential efficacy of **liraglutide** as a pharmacological intervention for managing severe **obesity** in patients with **Smith-Magenis syndrome**, a population often resistant to conv…
-
Mecobalamin + anti-VEGF combination trial protocol aims to enhance neuroprotection in retinal vein occlusion macular edema.
A randomized, double-blind trial will evaluate oral **mecobalamin** as an adjuvant to conbercept for **retinal vein occlusion**-related macular edema in **120** patients over 6 months.
-
Cholestatic Pruritus: Review Illuminates Pathophysiology and Advances in Targeted Therapies
**This review provides a critical update for clinicians and patients, underscoring the shift towards more effective, mechanism-based treatments for cholestatic pruritus.** For individuals suffering from **primary biliary cholangitis** an…
-
Ciclosporin effectively resolves steroid-refractory ocrelizumab-induced colitis in a woman with MS.
This case report offers a crucial insight for clinicians managing severe **ocrelizumab-induced colitis**, particularly when standard steroid treatments fail. **Ciclosporin** emerges as a viable salvage therapy, potentially averting the n…
-
Combinatorial in situ cancer vaccines elicit broad, enhanced antitumor responses by leveraging tumor antigens and immune mechanisms.
Combinatorial in situ cancer vaccines transform tumors into endogenous vaccine platforms, eliciting robust polyclonal cytotoxic T-cell responses and systemic antitumor immunity.
-
Carbetocin nasal spray fails to significantly improve hyperphagia in Prader-Willi syndrome in Phase 3 COMPASS PWS study.
Intranasal **carbetocin** 3.2 mg TID did not significantly reduce hyperphagia or anxiousness compared to placebo in **175** Prader-Willi syndrome participants.
-
GLP-1 Receptor Agonists Consistently Reduce Alcohol Consumption and Craving in Individuals with Alcohol Use Disorder
GLP-1 receptor agonists consistently reduce alcohol consumption and craving across clinical trials, observational data, and preclinical studies, suggesting a novel therapeutic strategy for **alcohol use disorder**.
-
GDF15 emerges as key appetite regulator via GFRAL, showing therapeutic promise for obesity
This review significantly advances our understanding of **GDF15**'s role in metabolic regulation, shifting its perception from a simple biomarker to a potent therapeutic target for **obesity**. For peptide users and biohackers, this high…
-
Orientin protects pancreatic beta-cells from STZ-induced damage by modulating oxidative stress, inflammation, apoptosis, and pyroptosis.
Orientin protected pancreatic beta-cells in a **streptozotocin (STZ)**-induced type 1 diabetes model, reducing inflammation, oxidative stress, apoptosis, and pyroptosis.
-
Semaglutide linked to transient CA 19-9 and CA-125 tumor biomarker elevation in patient
Semaglutide treatment in a 61-year-old patient caused significant, transient elevations in tumor biomarkers CA 19-9 (**717 kU/L**) and CA-125, normalizing within two months.
-
Cyclic Peptide Research Surges, Oral Delivery Advances, Driving Modern Drug Discovery Trends
This review highlights that **cyclic peptides are becoming an increasingly viable and versatile therapeutic modality**, particularly with advancements in oral delivery. For peptide users and biohackers, this signals a future where highly…
-
Review Explores Prophylactic vs. Selective Surfactant Strategies for Preterm Infant Respiratory Distress Syndrome
Review's background explores prophylactic vs. selective surfactant strategies for **Neonatal Respiratory Distress Syndrome** in preterm infants, aiming to reduce morbidity and mortality.
-
Cefotaxime plus polymyxin B achieves complete recovery in pan-resistant Klebsiella pneumoniae chest wall infection
This case highlights a crucial therapeutic strategy for clinicians facing dire situations with pan-resistant bacterial infections where standard treatments have failed. **The successful use of cefotaxime plus polymyxin B provides a poten…
-
Review Highlights Interleukin-11's Broad Immunomodulatory Roles Beyond Fibrosis, Influencing Innate and Adaptive Cell Plasticity
A comprehensive review reveals Interleukin-11 (IL-11) as a key immunomodulator, orchestrating plasticity in both innate and adaptive immune cells, extending its known pro-fibrotic functions.
-
Artificial Intelligence Identified as a New Commercial Determinant of Health, Shaping Population Well-being
Artificial intelligence is recognized as a novel commercial determinant of health, influencing public health outcomes through its pervasive economic and social impacts.
-
Generic Semaglutide Availability's Cost-Effectiveness Analyzed for Type 2 Diabetes Patients
This study models the potential cost-effectiveness of generic **semaglutide** for **Type 2 Diabetes** management, considering its future market entry.
-
LSG most cost-effective for severe obesity; ESG rivals semaglutide for lower BMI.
LSG is most cost-effective for severe obesity (£10,593/QALY). ESG is cost-effective vs. **semaglutide** for lower BMI (£7,267/QALY), and **semaglutide** dominates IGB.
-
Inpegsomatropin weekly injection to be evaluated against daily rhGH for idiopathic short stature in Phase III trial
The development of a **once-weekly Inpegsomatropin injection** represents a significant potential advancement in the management of **idiopathic short stature (ISS)**. If proven efficacious and safe, this long-acting formulation could dra…
-
Multi-ingredient supplement T+ targets testosterone and performance, with null hypotheses proposed
Onnit Labs' T+ supplement, with mucuna pruriens and longjack root, aims to boost testosterone and performance, but null effects are hypothesized.
-
Carbetocin and Oxytocin Regimens Compared with Tranexamic Acid for Postpartum Hemorrhage Prevention
While specific findings are not yet available, this study addresses a critical clinical question in maternal health. **Optimizing PPH prevention protocols** could significantly reduce maternal morbidity and mortality worldwide. If one of…
-
Holding during therapeutic hypothermia aims to reduce stress and boost bonding in mother-infant pairs
**Integrating maternal holding into therapeutic hypothermia protocols could significantly improve the emotional well-being and bonding for both mothers and infants.** If successful, this research could lead to immediate, low-cost modific…
-
Oxytocin's ability to boost nipple fluid collection for microRNA analysis explored in breast cancer pilot
**Successfully increasing nipple aspirate fluid (NAF) yield with oxytocin could revolutionize non-invasive breast cancer diagnostics and monitoring.** Enhanced NAF collection would make the analysis of crucial **microRNA** biomarkers mor…
-
Intranasal Oxytocin's Differential Modulation of Emotion Regulation and Neural Responses in Men to be Investigated
Understanding how different administration routes of **oxytocin** impact emotion regulation and neural activity could significantly advance therapeutic strategies for conditions characterized by emotional dysregulation. If intranasal del…
-
IV Oxytocin Infusion Investigated to Reduce Post-Hysterectomy Opioid Consumption in Double-Blinded RCT
If this trial demonstrates that IV oxytocin significantly reduces post-operative opioid consumption, it could **revolutionize pain management protocols** after gynecological surgeries. A successful outcome would provide a much-needed non…
-
Intranasal Oxytocin Investigated for Social Cognition, Repetitive Behaviors in Pediatric ASD
Intranasal oxytocin (Syntocinon®) was investigated in a Phase 2 randomized trial to improve social cognition and reduce repetitive behaviors in children and adolescents with **Autism Spectrum Disorders**.
-
Randomized trial to evaluate mazdutide for T2DM and NAFLD in semaglutide-treated patients
This trial addresses a critical unmet need for patients with **Type 2 Diabetes Mellitus** and **Nonalcoholic Fatty Liver Disease** who show insufficient response to standard GLP-1RA therapy like semaglutide. **Mazdutide**, a novel dual `…
-
Liraglutide added to insulin improved glycemic control, reduced weight in overweight T1D patients.
Liraglutide, added to insulin, improved glucose control, reduced weight, and lowered insulin doses in overweight Type 1 Diabetes patients over 26 weeks.
-
Randomized Trial Compares Liraglutide, Vildagliptin, Empagliflozin for Fatty Liver in T2DM
This randomized controlled trial holds profound implications for the clinical management of **NAFLD** in patients with **T2DM**, a demographic at exceptionally high risk for developing advanced liver disease. Identifying an effective ant…
-
Liraglutide's immune cell and anti-inflammatory cytokine modulation in obese Type 2 Diabetes patients investigated
A clinical trial investigated Liraglutide's effects on immune cell counts and anti-inflammatory cytokine profiles in obese Type 2 Diabetes patients.
-
Liraglutide's anti-atherogenic mechanisms in Type 2 Diabetes to be investigated via FDG-PET/CT
If this trial demonstrates that **liraglutide** significantly reduces **vascular inflammation** in **Type 2 Diabetes** patients, it would provide crucial mechanistic insights into its established cardiovascular benefits. This could reinf…
-
Liraglutide RCT aims to reduce cardiovascular risk markers in women with Polycystic Ovary Syndrome
A **Liraglutide** randomized controlled trial (n=70) will investigate if GLP-1 analog treatment reduces vascular thrombosis and early cardiovascular disease markers in women with **PCOS**.
-
Semaglutide significantly reduced BMI by up to 18.3% and improved SBP in obese individuals
Semaglutide significantly reduced BMI (up to **18.3%**) and improved systolic blood pressure in obese/overweight individuals, indicating potential renal benefits.
-
AI-Assisted Lifestyle Intervention vs. Tirzepatide for Obesity and New Type 2 Diabetes Management
This trial holds significant implications for the management of **obesity** and **type 2 diabetes**, particularly by exploring a scalable, non-pharmacological approach. If the AI-assisted intensive lifestyle intervention proves comparabl…
-
GLP-1 Receptor Agonists' long-term effects on blood glucose and body fat in Type 2 Diabetes patients evaluated.
This study evaluates the long-term efficacy of various GLP-1 Receptor Agonists on blood glucose and body fat in patients with Type 2 Diabetes over 1-4 years.
-
TAT-Beclin-1 peptide and TFEB activator C1 restore autophagy, protecting aging kidneys from septic AKI.
TAT-Beclin-1 peptide mitigated LPS-induced apoptosis in senescent renal cells, while TFEB activator C1 reduced LPS-induced AKI in aging mice by enhancing autophagy.
-
Engineered diselenide bridge protects insulin glargine from fibrillation and enhances stability
This study introduces a novel "dynamic engineering" strategy using nonstandard mutagenesis to significantly enhance the stability of peptide therapeutics like **insulin glargine**. **Improved thermal stability could eliminate the need fo…
-
Diosgenin mitigates oxazolone-induced ulcerative colitis in mice via Th2 pathway and pSTAT3 suppression
**Diosgenin's demonstrated efficacy in mitigating experimental colitis, comparable to the JAK inhibitor Tofacitinib, highlights its significant potential as a novel therapeutic agent for inflammatory bowel diseases.** This natural compou…
-
Griselimycin, a Macrocyclic Peptide, Exhibits "Inverse Chameleonicity" for Membrane Permeability
This groundbreaking discovery significantly **redefines our understanding of macrocyclic peptide permeability**, offering novel design principles for **beyond Rule of 5 (bRo5) drugs** that have historically struggled with bioavailability…
-
Nano-Rosmarinic Acid outperforms crude RA, protecting against pesticide-induced testicular toxicity in rats.
This study highlights the significant potential of **nanoformulation strategies to enhance the therapeutic efficacy of natural compounds** like Rosmarinic acid. For individuals concerned about environmental toxin exposure or seeking adju…
-
Multimodal Monitoring Strategy Detects Antineoplastic Cardiotoxicity in 30% of Cancer Patients, Guiding Personalized Care
This multimodal monitoring model offers a significant advancement for **personalized management of cardiotoxicity** in cancer patients. By identifying patients at high risk for cardiac dysfunction earlier, clinicians can implement intens…
-
VISTA Deficiency Exacerbates Autoimmune Uveitis by Promoting Microglial TLR4/MyD88/NF-κB Activation
This research identifies VISTA as a crucial regulator of ocular immune homeostasis, offering a promising new therapeutic target for **autoimmune uveitis** and other neuroinflammatory conditions. The finding that VISTA downregulation driv…
-
tPA protects kidneys from Candida infection by suppressing RTEC apoptosis via LRP1/ERK1/2 signaling
This research reveals a novel host-protective mechanism against **invasive candidiasis** and suggests a promising therapeutic strategy. **Clinically approved tPA**, traditionally used as a thrombolytic, could be repurposed as an adjuncti…
-
MitoQ ameliorates diabetic cardiomyopathy by inhibiting mtROS-TXNIP-NLRP3 pathway activation in mice
**MitoQ offers a promising therapeutic strategy for diabetic cardiomyopathy by directly targeting mitochondrial dysfunction and inflammation.** This research highlights the critical role of the `mtROS/TXNIP/NLRP3` axis in DCM pathogenesi…
-
Sphingosine Kinase 1 (SphK1) inhibition accelerates corneal epithelial wound healing by reducing TGF-β/Smad signaling
This research highlights a novel therapeutic strategy for **corneal injury management**: targeting `S1P` signaling. By inhibiting `SphK1`, clinicians could potentially accelerate epithelial wound healing and significantly reduce the risk…
-
Bioactive Peptide Bioavailability: Review Uncovers Barriers, Transport, and Enhancement Strategies
This review offers a critical roadmap for peptide developers and biohackers aiming to overcome the persistent challenge of poor peptide bioavailability. **Optimizing peptide delivery and absorption** is paramount for translating their di…
-
Seipin knockdown ameliorates Alzheimer's cognitive deficits by reducing ferroptosis via glycine pathway
This research identifies the `BSCL2`-glycine-ferroptosis axis as a novel and promising therapeutic target for **Alzheimer's disease**. **Targeting Seipin or modulating glycine levels could offer a new strategy to prevent neurodegeneratio…
-
Dermaseptin DMS-DA6 outperforms linezolid in resolving N. brasiliensis-induced actinomycetoma in mice
**DMS-DA6 presents a compelling, less frequent, and potentially less toxic alternative to conventional antibiotics for treating actinomycetoma.** This could significantly improve patient adherence and reduce the burden of prolonged, high…
-
5-eMAL Prodrug Greatly Enhances Cancer Cell Photoinactivation and PpIX Production Over 5-ALA
This research introduces **5-eMAL** as a superior alternative to **5-ALA** for photodynamic therapy, addressing critical limitations of the current clinical standard. **The enhanced cellular uptake and stability of 5-eMAL could significa…
No loaded studies match that filter. or browse the full 8,080.
Go deeper on one peptide
- Semaglutide1011
- Tirzepatide722
- Insulin534
- Liraglutide479
- Oxytocin354
- MGF196
- LL-37165
- Retatrutide153
- Thymosin Alpha-1147
- MOTS-c121
- BPC-157115
- IGF-1109
- GHRP-6107
- SS-3198
- MK-67796
- GHK-Cu94
- GHRP-292
- Sermorelin89
- Orexin a87
- Epitalon83
- Melanotan II80
- Cagrilintide74
- Selank74
- Semax74
- PT-14172
- P2164
- HGH45
- Humanin45
- Ipamorelin45
- Dulaglutide42